The finding showed that both the CNV and SNV of the POLD1 gene were statistically significant with the clinical outcomes of OS, PFS, and DSS in ccRCC patients (Figure 3A,B). The gene discussed is POLD1; the disease is nonpapillary renal cell carcinoma.